{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:42Z","timestamp":1790621502368,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.canlet.2025.217522","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:58:39Z","timestamp":1738897119000},"page":"217522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer"],"prefix":"10.1016","volume":"616","author":[{"given":"Sugarniya","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-5310","authenticated-orcid":false,"given":"Varinder","family":"Jeet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taskeen","family":"Janjua Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuran","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilakshmi","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-6247","authenticated-orcid":false,"given":"Jyotsna","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2023","key":"10.1016\/j.canlet.2025.217522_bib1","first-page":"191","article-title":"Update on prostate cancer epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2025.217522_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24020910","article-title":"Emerging hallmarks of metabolic reprogramming in prostate cancer","volume":"24","author":"Lasorsa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217522_bib3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2025.217522_bib4","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41388-018-0582-8","article-title":"The ERK and JNK pathways in the regulation of metabolic reprogramming","volume":"38","author":"Papa","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217522_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217156","article-title":"Glycolysis, the sweet appetite of the tumor microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217522_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Pujana-Vaquerizo","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib7","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00432-022-04371-w","article-title":"Metabolic changes during prostate cancer development and progression","volume":"149","author":"Beier","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.canlet.2025.217522_bib8","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-17-1957","article-title":"Hyperpolarized [1-(13)C]-Pyruvate magnetic resonance spectroscopic imaging of prostate cancer in vivo predicts efficacy of targeting the Warburg effect","volume":"4","author":"Scroggins","year":"2018","journal-title":"Clin. Cancer Res.\u202f: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2025.217522_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217522_bib10","first-page":"10","article-title":"The implications of PDK1-4 on tumor energy metabolism, aggressiveness and therapy resistance","author":"Atas","year":"2020","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.canlet.2025.217522_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcancer.2017.04.014","article-title":"PDK1: at the crossroad of cancer signaling pathways","volume":"48","author":"Gagliardi","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217522_bib12","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mc.23531","article-title":"PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming","volume":"62","author":"Ma","year":"2023","journal-title":"Mol Carcinogen"},{"key":"10.1016\/j.canlet.2025.217522_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216425","article-title":"Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing","volume":"577","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2025.217522_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1568026618666180523105756","article-title":"Inhibition of pyruvate dehydrogenase kinase as a therapeutic strategy against cancer","volume":"18","author":"Sradhanjali","year":"2018","journal-title":"Current topics in medicinal chemistry"},{"key":"10.1016\/j.canlet.2025.217522_bib15","article-title":"Master kinase PDK1 in tumorigenesis","volume":"1878","author":"Zheng","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217522_bib16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad","year":"2021","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib17","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.18632\/oncotarget.14527","article-title":"Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217522_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/or.2016.5253","article-title":"PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.217522_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-Dependent metabolic reprogramming dictates metastatic potential in breast cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217522_bib20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41416-023-02418-4","article-title":"BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARgamma\/PDK1 dependent manner","volume":"129","author":"Wang","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib21","doi-asserted-by":"crossref","first-page":"16729","DOI":"10.1007\/s00432-023-05416-4","article-title":"SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1\/AKT axis","volume":"149","author":"Huang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217522_bib22","article-title":"Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration","volume":"14","author":"Tao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217522_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164133","article-title":"Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC","volume":"13","author":"De Rosa","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217522_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-022-00300-0","article-title":"PDK1-and PDK2-mediated metabolic reprogramming contributes to the TGF\u03b21-promoted stem-like properties in head and neck cancer","volume":"10","author":"Sun","year":"2022","journal-title":"Cancer Metab"},{"key":"10.1016\/j.canlet.2025.217522_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100140","article-title":"Targeting PDK1 for chemosensitization of cancer cells","volume":"9","author":"Emmanouilidi","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217522_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3892\/ijo.2020.5098","article-title":"Inhibition of pyruvate dehydrogenase kinase-1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming","volume":"57","author":"Xu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217522_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s40001-023-01425-8","article-title":"Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model","volume":"28","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.canlet.2025.217522_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002227","article-title":"Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy","volume":"21","author":"Han","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2025.217522_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2159-8290.CD-14-1057","article-title":"A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer","volume":"5","author":"Stegeman","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217522_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143582","article-title":"Allele-specific MicroRNA-mediated regulation of a glycolysis gatekeeper PDK1 in cancer metabolism","volume":"13","author":"Subramaniam","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217522_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136968","article-title":"Investigating the common pharmacophoric points of PDK1 inhibitors as anti-cancer agents using an alignment independent 3D-QSAR, molecular docking and molecular dynamic simulation","volume":"1300","author":"Piri","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.canlet.2025.217522_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1275749","article-title":"A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway","volume":"14","author":"Park","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217522_bib33","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2023.11922","article-title":"PDK1 inhibition reduces autophagy and cell senescence through the PI3K\/AKT signalling pathway in a cigarette smoke mouse emphysema model","volume":"25","author":"Zhang","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2025.217522_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116008","article-title":"Targeting the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation","volume":"264","author":"Gan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217522_bib35","article-title":"Recent advances in pyruvate dehydrogenase kinase inhibitors: structures, inhibitory mechanisms and biological activities","author":"Yiyang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.canlet.2025.217522_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2025.217522_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.7150\/jca.92521","article-title":"Disruption of autophagic flux and treatment with the PDPK1 inhibitor GSK2334470 synergistically inhibit renal cell carcinoma pathogenesis","volume":"15","author":"Zhou","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110467","article-title":"Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models","volume":"378","author":"Guo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2025.217522_bib39","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1021\/acs.jmedchem.3c01197","article-title":"Reprogramming energy metabolism with synthesized PDK inhibitors based on dichloroacetate derivatives and targeted delivery systems for enhanced cancer therapy","volume":"66","author":"She","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217522_bib40","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1021\/acs.jmedchem.5b01828","article-title":"Unexpected discovery of dichloroacetate derived adenosine triphosphate competitors targeting pyruvate dehydrogenase kinase to inhibit cancer proliferation","volume":"59","author":"Zhang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217522_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112840","article-title":"Dichloroacetate attenuates brain injury through inhibiting neuroinflammation and mitochondrial fission in a rat model of sepsis-associated encephalopathy","volume":"140","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2025.217522_bib42","article-title":"Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217522_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177744","article-title":"Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: a potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions","volume":"12","author":"Sradhanjali","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217522_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110467","article-title":"Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models","volume":"378","author":"Guo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2025.217522_bib45","first-page":"313","article-title":"Use of sodium dichloroacetate for cancer treatment: a scoping review","volume":"84","author":"Bianchi","year":"2024","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.canlet.2025.217522_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13020-022-00699-0","article-title":"Dicoumarol: from chemistry to antitumor benefits","volume":"17","author":"Silva","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.canlet.2025.217522_bib47","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41467-022-29368-4","article-title":"Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation","volume":"13","author":"Levina","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217522_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib49","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acsbiomaterials.0c01354","article-title":"Protein nanoparticles for enhanced oral delivery of coenzyme-Q10: in vitro and in silico studies","volume":"9","author":"Banun","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.canlet.2025.217522_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.canlet.2025.217522_bib51","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.drudis.2020.06.027","article-title":"Nanovehicles for co-delivery of anticancer agents","volume":"25","author":"Zeinali","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.canlet.2025.217522_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051362","article-title":"Lactoferrin and nanotechnology: the potential for cancer treatment","volume":"15","author":"Tran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2025.217522_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fonc.2018.00200","article-title":"Bovine milk lactoferrin selectively kills highly metastatic prostate cancer PC-3 and osteosarcoma MG-63 cells in vitro","volume":"8","author":"Guedes","year":"2018","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.canlet.2025.217522_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43725-3","article-title":"Therapeutic potential of lactoferrin-coated iron oxide nanospheres for targeted hyperthermia in gastric cancer","volume":"13","author":"Attri","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217522_bib55","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1039\/D1NR03553C","article-title":"Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma","volume":"13","author":"Janjua","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2025.217522_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2023.03.040","article-title":"Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma","volume":"357","author":"Janjua","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.canlet.2025.217522_bib57","first-page":"4499","article-title":"Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease","volume":"62","author":"LaTulippe","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217522_bib58","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","article-title":"Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy","volume":"22","author":"Yu","year":"2004","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.canlet.2025.217522_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217522_bib60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217522_bib62","doi-asserted-by":"crossref","DOI":"10.1063\/1.4962992","article-title":"Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry","volume":"10","author":"Clayton","year":"2016","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.canlet.2025.217522_bib63","article-title":"Nanoparticles surface chemistry influence on protein corona composition and inflammatory responses","volume":"12","author":"Gonz\u00e1lez-Garc\u00eda","year":"2022","journal-title":"Nanomaterials-Basel"},{"key":"10.1016\/j.canlet.2025.217522_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091862","article-title":"Lactoferrin-conjugated nanoparticles as new antivirals","volume":"14","author":"Krzyzowska","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2025.217522_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2025.217522_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-7-64","article-title":"Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process","volume":"7","author":"Chandran","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib67","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10637-015-0221-y","article-title":"A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Invest New Drug"},{"key":"10.1016\/j.canlet.2025.217522_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11635","article-title":"HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity","volume":"7","author":"Semba","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217522_bib69","article-title":"PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1alpha","volume":"11","author":"Wei","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.canlet.2025.217522_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590576","article-title":"Molecular crosstalk between MYC and HIF in cancer","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217522_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2025.217522_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.canlet.2025.217522_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0331-3","article-title":"Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation","volume":"14","author":"Zhou","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217522_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28737-3","article-title":"The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217522_bib75","first-page":"E363","article-title":"Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma","volume":"325","author":"Zhang","year":"2023","journal-title":"Am J Physiol-Endoc M"},{"key":"10.1016\/j.canlet.2025.217522_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113830","article-title":"Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models","volume":"433","author":"Guo","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2025.217522_bib77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217522_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-9056(18)30907-2","article-title":"Targeting lactate dehydrogenase-A promotes docetaxel induced cytotoxicity predominantly in castration-resistant prostate cancer cells","volume":"17","author":"Muramatsu","year":"2018","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.canlet.2025.217522_bib79","doi-asserted-by":"crossref","first-page":"26558","DOI":"10.1074\/jbc.M109.063255","article-title":"Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells","volume":"285","author":"Xiao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217522_bib80","doi-asserted-by":"crossref","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells","volume":"7","author":"Ippolito","year":"2016","journal-title":"Oncotarget"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:02:44Z","timestamp":1760742164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":79,"alternative-id":["S0304383525000862"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217522","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217522"}}